{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:18:12Z","timestamp":1793787492666,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajogmf.2025.101865","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T15:21:38Z","timestamp":1765120898000},"page":"101865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatitis C treatment during pregnancy: time for a practice change"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7668-5638","authenticated-orcid":false,"given":"Karley","family":"Dutra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Fenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2025.101865_bib0001","series-title":"Jawetz, Melnick, & Adelberg\u2019s medical microbiology, 28e","article-title":"Hepatitis viruses","author":"Riedel","year":"2019"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101865_bib0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.ajogmf.2025.101865_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/v16111739","article-title":"Acute hepatitis C: current status and future perspectives","volume":"16","author":"Fasano","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0004","unstructured":"Centers for Disease Control and Prevention. Viral Hepatitis Surveillance Report \u2013 United States, 2023. https:\/\/www.cdc.gov\/hepatitis-surveillance-2023\/about\/index.html, Published April 2025. Accessed September 1, 2025."},{"issue":"2","key":"10.1016\/j.ajogmf.2025.101865_bib0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/HEP.0000000000000927","article-title":"Estimating hepatitis C prevalence in the United States, 2017-2020","volume":"81","author":"Hall","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0006","article-title":"The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019","volume":"11","author":"Yang","year":"2023"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(20)30359-9","article-title":"Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study","volume":"6","author":"Dugan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ajogmf.2025.101865_bib0008","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1473-3099(24)00307-4","article-title":"WHO\u2019s 2024 global hepatitis report","volume":"24","author":"Burki","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/AOG.0000000000005306","article-title":"Risk factors for perinatal transmission of hepatitis C virus","volume":"142","author":"Prasad","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102727","article-title":"Global epidemiology, natural history, maternal-to-child transmission, and treatment with DAA of pregnant women with HCV: a systematic review and meta-analysis","volume":"74","author":"Quek","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.ajogmf.2025.101865_bib0011","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0012","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciac270","article-title":"Overall vertical transmission of hepatitis C virus, transmission net of clearance, and timing of transmission","volume":"76","author":"Ades","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ajogmf.2025.101865_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2024-067261","article-title":"Hepatitis C virus testing among perinatally exposed children: 2018 to 2020","volume":"154","author":"Woodworth","year":"2024","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101865_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2023-064745","article-title":"Factors associated with perinatal hepatitis C screening among exposed children: 2016\u20132020","volume":"154","author":"Kuncio","year":"2024","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ajogmf.2025.101865_bib0015","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1136\/adc.2004.059436","article-title":"When does mother to child transmission of hepatitis C virus occur?","volume":"90","author":"Mok","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"10","key":"10.1016\/j.ajogmf.2025.101865_bib0016","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajogmf.2025.101865_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0018","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral hepatitis in pregnancy: ACOG clinical practice guideline no. 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0019","doi-asserted-by":"crossref","first-page":"B8","DOI":"10.1016\/j.ajog.2021.06.008","article-title":"Society for Maternal-Fetal Medicine Consult Series #56: hepatitis C in pregnancy-updated guidelines: replaces consult number 43, November 2017","volume":"225","author":"Dotters-Katz","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101865_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ajog.2024.06.028","article-title":"Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the treatment in pregnancy for hepatitis C community of practice","volume":"231","author":"Gupta","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0021","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/AOG.0000000000004760","article-title":"Postpartum follow-up care for pregnant persons with opioid use disorder and hepatitis C virus infection","volume":"139","author":"Jarlenski","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ajogmf.2025.101865_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277987","article-title":"Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States","volume":"17","author":"Yee","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0024","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2022.05.016","article-title":"Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission","volume":"77","author":"Kushner","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.ajogmf.2025.101865_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.24770","article-title":"Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101865_bib0026","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/AOG.0000000000005703","article-title":"Pregnancy outcomes in patients with hepatitis C virus infection","volume":"144","author":"Hughes","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ajogmf.2025.101865_bib0027","first-page":"3475","article-title":"Association between hepatitis C infection during pregnancy with maternal and neonatal outcomes: a systematic review and meta-analysis","volume":"27","author":"Shen","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.ajogmf.2025.101865_bib0028","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1111\/j.1365-2893.2011.01436.x","article-title":"Pregnancy outcomes associated with viral hepatitis","volume":"18","author":"Reddick","year":"2011","journal-title":"J Viral Hepat"},{"issue":"12","key":"10.1016\/j.ajogmf.2025.101865_bib0029","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/jvh.12430","article-title":"Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies","volume":"22","author":"Huang","year":"2015","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/14767058.2015.1009438","article-title":"Outcomes of pregnancies complicated by liver cirrhosis, portal hypertension, or esophageal varices","volume":"29","author":"Puljic","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0031","first-page":"293","article-title":"The impact of liver cirrhosis in pregnancy on adverse maternal and infant outcomes: a meta-analysis","volume":"52","author":"Zhi-xiu","year":"2025","journal-title":"J Int Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ajogmf.2025.101865_bib0032","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1086\/497701","article-title":"Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy","volume":"192","author":"Mast","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0033","first-page":"228","article-title":"Testing infants and children with perinatal exposure to hepatitis C virus","volume":"110","author":"Sandul","year":"2024","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101865_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7204a1","article-title":"CDC recommendations for hepatitis C testing among perinatally exposed infants and children\u2014United States, 2023","volume":"72","author":"Panagiotakopoulos","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.ajogmf.2025.101865_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jpids\/piae066","article-title":"Pediatric hepatitis C screening by maternal hepatitis C infection status during pregnancy","volume":"13","author":"DiNicola","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101865_bib0036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/430601","article-title":"Three broad modalities in the natural history of vertically acquired hepatitis C virus infection","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0037","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-068565","article-title":"Disparities in linkage to care among children with hepatitis C virus in the United States","volume":"155","author":"Curtis","year":"2025","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0038","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/QCO.0000000000000856","article-title":"Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children","volume":"35","author":"Honegger","year":"2022","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101865_bib0039","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/cid\/ciae595","article-title":"Sofosbuvir\/velpatasvir pharmacokinetics, safety, and efficacy in pregnant people with hepatitis C virus","volume":"80","author":"Chappell","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0040","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101865_bib0041","first-page":"134","article-title":"Safety and efficacy of treatment for chronic hepatitis C during pregnancy: a prospective observational study in Srinagar, India","volume":"22","author":"Yattoo","year":"2023","journal-title":"Clin Liver Dis (Hoboken)."},{"issue":"1, Suppl","key":"10.1016\/j.ajogmf.2025.101865_bib0042","first-page":"e221","article-title":"THU-137-DAA therapy in women of child bearing age: accidental conception during therapy and pregnancy outcome","volume":"70","author":"El-Sayed","year":"2019","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0043","doi-asserted-by":"crossref","first-page":"643","DOI":"10.47162\/RJME.61.3.02","article-title":"Global hepatitis C elimination: history, evolution, revolutionary changes and barriers to overcome","volume":"61","author":"Oancea","year":"2020","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101865_bib0044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","article-title":"Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction","volume":"5","author":"Geddawy","year":"2017","journal-title":"J Transl Int Med"},{"issue":"Suppl 1","key":"10.1016\/j.ajogmf.2025.101865_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.ajogmf.2025.101865_bib0046","article-title":"Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C","volume":"8","author":"Huttman","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101865_bib0047","article-title":"Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: the HepNet acute HCV-V study","volume":"5","author":"Maasoumy","year":"2023","journal-title":"JHEP Rep"},{"issue":"9","key":"10.1016\/j.ajogmf.2025.101865_bib0048","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1002\/jmv.27877","article-title":"Sofosbuvir-based therapy for late pregnant women and infants with severe chronic hepatitis C: a case series study","volume":"94","author":"Zeng","year":"2022","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.ajogmf.2025.101865_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens13060508","article-title":"Direct-acting antiviral agents in prevention of maternal-fetal transmission of hepatitis C virus in pregnancy","volume":"13","author":"Hartley","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0050","unstructured":"Chappell CA. Sofosbuvir\/velpatasvir treatment of chronic hepatitis C during pregnancy (STORC). Available: https:\/\/clinicaltrials.gov\/study\/NCT05140941. Accessed August 27, 2025."},{"key":"10.1016\/j.ajogmf.2025.101865_bib0051","unstructured":"Study of the pharmacokinetics and safety of glecaprevir\/pibrentasvir initiated in pregnancy in women with hepatitis C with and without HIV. Available: https:\/\/clinicaltrials.gov\/study\/NCT07040319. Accessed August 25, 2025."},{"key":"10.1016\/j.ajogmf.2025.101865_bib0052","unstructured":"Hiebert L. The treatment in pregnancy for hepatitis C (TiP-HepC) registry. Available:https:\/\/clinicaltrials.gov\/study\/NCT05368974. Accessed August 25, 2025."},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101865_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens13040321","article-title":"Hepatitis C prevalence and birth outcomes among pregnant women in the United States: a 2010-2020 population study","volume":"13","author":"Wasuwanich","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.ajogmf.2025.101865_bib0054","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf443","article-title":"Sofosbuvir\/velpatasvir concentrations in the breastmilk of postpartum women with opioid use disorder receiving treatment for hepatitis C virus: a pharmacokinetic study","author":"Chappell","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0055","first-page":"e112","article-title":"Association of postpartum inpatient consultation compared with outpatient referral with hepatitis C virus treatment completion","volume":"2","author":"McCrary","year":"2025","journal-title":"O G Open"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101865_bib0056","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2022.07.017","article-title":"Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach","volume":"163","author":"Kushner","year":"2022","journal-title":"Gastroenterology"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933325002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933325002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:56:29Z","timestamp":1777985789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933325002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2589933325002630"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101865","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C treatment during pregnancy: time for a practice change","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101865"}}